Form 4 for IBIO iBio, Inc.
Accepted 2023-04-03 00:00:00 ET · period of report 2023-03-31 · accession 0001104659-23-040819 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-03 | 2023-03-31 | IBIO | Brenner Martin | See Remarks | A - Grant | $0.00 | +50.0K | 266.2K | +23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-31 | A | A | 50,000 | $0.00 | 266,159 | D | — | — | (F1) Consists of 50,000 shares of iBio, Inc. (the "Company") common stock, $0.001 par value per share (the "Common Stock") represented by 50,000 restricted stock units ("RSUs") granted under the Company's 2020 Omnibus Equity Incentive Plan, (the "2020 Plan"). Each RSU represents a contingent right to receive one share of Common Stock. The 50,000 RSUs vest pro rata quarterly over 12 months beginning April 1, 2023. |